Biocompatibility of icodextrin

被引：26

作者：

Cooker, LA ^{[1
]}

Holmes, CJ ^{[1
]}

Hoff, CM ^{[1
]}

机构：

[1] Baxter Healthcare Corp, Renal Div Res, McGaw Pk, IL 60085 USA

来源：

KIDNEY INTERNATIONAL | 2002年 / 62卷

关键词：

renal replacement therapy; CAPD; APD; dialysate; membrane permeability; ultrafiltration; peritoneal cavity homeostasis;

D O I：

10.1046/j.1523-1755.62.s81.6.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：S34 / S45

页数：12

共 103 条

[1]

Alsop, 1994, PERITON DIAL INT S2, V14, pS5

[2]

Bajo MA, 2000, PERITON DIALYSIS INT, V20, P742

[3]

Barre DE, 1999, ADV PERIT D, V15, P12

[4]

Basok A, 2001, J AM SOC NEPHROL, V12, P695, DOI 10.1681/ASN.V124695

[5] AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression [J].

Boulanger, E ;

Wautier, MP ;

Wautier, JL ;

Boval, B ;

Panis, Y ;

Wernert, N ;

Danze, PM ;

Dequiedt, P .

KIDNEY INTERNATIONAL, 2002, 61 (01) :148-156

[6]

BRULEZ HFH, 1995, PERITON DIALYSIS INT, V15, pS24

[7]

Chen CJ, 1998, ADV PERIT D, V14, P116

[8]

Chen JY, 1997, PERITON DIALYSIS INT, V17, P455

[9]

Chung SH, 2000, PERITON DIALYSIS INT, V20, pS57

[10]

Combet S, 2000, J AM SOC NEPHROL, V11, P717, DOI 10.1681/ASN.V114717

← 1 2 3 4 5 6 7 8 9 10 →